Skip to main content
Journal cover image

Upfront Magnetic Resonance Imaging-Guided Stereotactic Laser-Ablation in Newly Diagnosed Glioblastoma: A Multicenter Review of Survival Outcomes Compared to a Matched Cohort of Biopsy-Only Patients.

Publication ,  Journal Article
Mohammadi, AM; Sharma, M; Beaumont, TL; Juarez, KO; Kemeny, H; Dechant, C; Seas, A; Sarmey, N; Lee, BS; Jia, X; Fecci, PE; Baehring, J ...
Published in: Neurosurgery
December 1, 2019

BACKGROUND: Laser ablation (LA) is used as an upfront treatment in patients with deep seated newly diagnosed Glioblastoma (nGBM). OBJECTIVE: To evaluate the outcomes of LA in patients with nGBM and compare them with a matched biopsy-only cohort. METHODS: Twenty-four nGBM patients underwent upfront LA at Cleveland clinic, Washington University in St. Louis, and Yale University (6/2011-12/2014) followed by chemo/radiotherapy. Also, 24 out of 171 nGBM patients with biopsy followed by chemo/radiotherapy were matched based on age (< 70 vs ≥ 70), gender, tumor location (deep vs lobar), and volume (<11 cc vs ≥11 cc). Progression-free survival (PFS), overall survival (OS), and disease-specific PFS and OS were outcome measures. Three prognostic groups were identified based on extent of tumor ablation by thermal-damage-threshold (TDT)-lines. RESULTS: The median tumor volume in LA (n = 24) and biopsy only (n = 24) groups was 9.3 cm3 and 8.2 cm3 respectively. Overall, median estimate of OS and PFS in LA cohort was 14.4 and 4.3 mo compared to 15.8 mo and 5.9 mo for biopsy only cohort. On multivariate analysis, favorable TDT-line prognostic groups were associated with lower incidence of disease specific death (P = .03) and progression (P = .05) compared to other groups including biopsy only cohort. Only age (<70 yr, P = .02) and tumor volume (<11 cc, P = .03) were favorable prognostic factors for OS. CONCLUSION: The maximum tumor coverage by LA followed by radiation/chemotherapy is an effective treatment modality in patients with nGBM, compared to biopsy only cohort. The TDT-line prognostic groups were independent predictor of disease specific death and progression after LA.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Neurosurgery

DOI

EISSN

1524-4040

Publication Date

December 1, 2019

Volume

85

Issue

6

Start / End Page

762 / 772

Location

United States

Related Subject Headings

  • Tumor Burden
  • Treatment Outcome
  • Survival Rate
  • Retrospective Studies
  • Neurology & Neurosurgery
  • Multivariate Analysis
  • Middle Aged
  • Male
  • Magnetic Resonance Imaging
  • Laser Therapy
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Mohammadi, A. M., Sharma, M., Beaumont, T. L., Juarez, K. O., Kemeny, H., Dechant, C., … Leuthardt, E. C. (2019). Upfront Magnetic Resonance Imaging-Guided Stereotactic Laser-Ablation in Newly Diagnosed Glioblastoma: A Multicenter Review of Survival Outcomes Compared to a Matched Cohort of Biopsy-Only Patients. Neurosurgery, 85(6), 762–772. https://doi.org/10.1093/neuros/nyy449
Mohammadi, Alireza M., Mayur Sharma, Thomas L. Beaumont, Kevin O. Juarez, Hanna Kemeny, Cosette Dechant, Andreas Seas, et al. “Upfront Magnetic Resonance Imaging-Guided Stereotactic Laser-Ablation in Newly Diagnosed Glioblastoma: A Multicenter Review of Survival Outcomes Compared to a Matched Cohort of Biopsy-Only Patients.Neurosurgery 85, no. 6 (December 1, 2019): 762–72. https://doi.org/10.1093/neuros/nyy449.
Mohammadi AM, Sharma M, Beaumont TL, Juarez KO, Kemeny H, Dechant C, Seas A, Sarmey N, Lee BS, Jia X, Fecci PE, Baehring J, Moliterno J, Chiang VL, Ahluwalia MS, Kim AH, Barnett GH, Leuthardt EC. Upfront Magnetic Resonance Imaging-Guided Stereotactic Laser-Ablation in Newly Diagnosed Glioblastoma: A Multicenter Review of Survival Outcomes Compared to a Matched Cohort of Biopsy-Only Patients. Neurosurgery. 2019 Dec 1;85(6):762–772.
Journal cover image

Published In

Neurosurgery

DOI

EISSN

1524-4040

Publication Date

December 1, 2019

Volume

85

Issue

6

Start / End Page

762 / 772

Location

United States

Related Subject Headings

  • Tumor Burden
  • Treatment Outcome
  • Survival Rate
  • Retrospective Studies
  • Neurology & Neurosurgery
  • Multivariate Analysis
  • Middle Aged
  • Male
  • Magnetic Resonance Imaging
  • Laser Therapy